Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
Cybin (HELP) is now covered by TD Cowen. They set a "buy" rating and a $8.00 price target on the stock.
Cybin Inc (HELP) Reports Positive Phase 2 Anxiety Study Data [Yahoo! Finance]
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer [Yahoo! Finance]
Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer